A real-time reverse transcription polymerase chain reaction (RT-PCR) method is described that enabled the detection and quantification of E2A±PBX1 fusion gene transcripts associated with t(1;19). The method was highly reproducible and offered exceptional sensitivity at 5 fg of fusion transcript per reaction, without the need for a nested PCR primer design. To illustrate the usefulness of this new technology the E2A±PBX1 fusion gene transcript expression level for several human leukaemia cell lines that are positive and negative for cytogenetically detectable t(1;19) was determined. The RCH±ACV had a threefold higher expression of E2A±PBX1 transcripts (600 transcripts per cell) than the other t(1;19) positive 697 (150 transcripts per cell). The only other cell line with detectable E2A± PBX1 was CEM, but the level of expression was , 1 transcript per cell.
Translocation t(1;19) is detected in 3±5% of childhood and 3% of adult acute lymphocytic leukaemia (ALL) cases (Crist et al, 1990; Rambaldi et al, 1996) . This translocation fuses exons I to XIII of the E2A gene (19p13) with exons II to VIII of the PBX1 (1q23) (Carroll et al, 1984) . E2A codes for a helix-loop-helix transcription factor, whereas PBX encodes a homeobox gene, and the fusion protein produced has malignant potential (Kamps et al, 1991) . A reverse transcription polymerase chain reaction (RT-PCR) method using a nested primer design has been described previously (van Dongen et al, 1999) , and has demonstrated considerable detection capabilities. However, the assay does not permit quantification of the fusion gene transcripts for the evaluation of minimal residual disease and other uses. This report describes a single primer set design that uses realtime PCR for the detection and quantification of E2A±PBX1 fusion gene transcripts. Using this method the level of fusion gene expression of two cell lines bearing t(1;19) was determined.
METHODS

Construction of E2A±PBX1 fusion gene runoff transcripts.
RNA was extracted from the 697 (CCL-119, American Type Culture Collection (ATCC, Manassas, VA, USA) cell line (1 Â 10 7 cells) using a Qiagen RNAeasye mini column as directed (Qiagen, Santa Clara, CA, USA). Firststrand cDNA was produced using the reverse transcription (RT) methods described by van Dongen et al (1999) with modifications as described. Whole RNA (1 mg) was primed with the 100 ng PBX1-E3 primer (Table I ) (MWG Biotech, High Point, NC, USA), then mixed with 0´5 mmol/l dNTPs (Roche, Pleasanto, CA, USA), five units Stratascripte reverse transcriptase (Stratagene, La Jolla, CA, USA), and 1 unit RNase inhibitor (Eppendorf, Hamburg, Germany) in 20-ml of 1Â buffer (supplied with RT enzyme). This RT cocktail was reacted for 50 min at 428C followed by 5 min at 958C. From the initial cDNA strand, a smaller cDNA product was generated using PCR primers E2A±A and PBX1-B (Table I) . PCR conditions were as described by van Dongen et al (1999) , and produced a single 373 basepair band. This PCR product was cloned into a pPCR-Script used to generate runoff RNA transcripts of the E2A±PBX1 fusion gene. To determine which plasmids contained a correctly orientated and sized insert, the colonies were screened using a PCR methodology. Using the M13 (220) primer, which is proximal to the T7 promoter sequence of the plasmid, and an E2A specific primer (E2A±A), 1 ml of the overnight culture was directly assayed using PCR. The 20 ml PCR consisted of 0´25 mmol/l dNTPs, 30 ng of forward and reverse primer, and 2 units of AmpliTaqe polymerase (Applied BioSystems, Redwood City, CA, USA) with the supplied buffer A. Products were run on a 1% agarose ethidium bromide-stained gel, and those reactions that generated a correctly sized product, 373 bp plus 223 bp of flanking plasmid sequences, were selected. Plasmid DNA was isolated from the selected overnight cultures using Qiagen Mini Plasmid extraction columns, as directed. Selected plasmid DNAs were sequenced by automated fluorescent sequencing and the sequences compared with the published E2A (Accession M31222, exons I±XIII) PBX1 (Accession M86546, exons I-VIII) gene sequences. A single error-free plasmid was subsequently used to generate runoff RNA transcripts.
Circular plasmid DNA was linearized by restriction of the single SacI site located distal to the plasmid's T7 promoter site. Large amounts of runoff RNA transcripts were produced using the MegaShortScripte T7 kit as directed (Ambion, Austin, TX, USA). To eliminate the contaminating plasmid DNA the runoffs were processed though a Qiagen RNA mini column and the product was then restricted with HaeIII (several sites between the real-time primers), then treated with DNase I, and passed through an RNA mini column. Real-time PCR (below) was used to directly (no RT step) screen the runoff RNA transcripts to ensure that no residual plasmid DNA was present as a contaminant. The quantity of the runoff transcript was initially determined by spectrophotometer and then confirmed using a RiboGreen TM RNA quantification kit (Molecular Probes, Eugene, OR, USA).
Design of real-time primers. Real-time PCR primers were manually designed and then tested using primer express Software (Applied Biosystems) ( Table I) . Guidelines for primer design, as suggested by Applied Biosystems, were adhered to tightly. Real-time PCR primers E2A±PBX1-F1 and E2A±PBX1-R are able to detect the two different splice variants as originally described by van Dongen et al (1999) . PCR primers were proofed using the selected E2A± PBX1 fusion gene plasmid. A TaqMane probe (E2A± PBX1-D) was designed such that it anneals to the 5 H end of PBX1 exon II and was labelled 5
H with the reporter dye tetrachloro-6-carboxyfluorescein (TET) as well as 3 H with the quencher dye 6-carboxytetramethylrhodamine (TAMRA) (MWG Biotech).
RT reactions. First-strand cDNA, generated from runoff RNA transcripts mixed in with background RNA (0´5 mg of human colon RNA per 20 ml of RT reaction) (Stratagene), was used to construct a standard curve for E2A±PBX1 fusion gene expression. The RT reaction cocktail consisted of 1Â buffer (Stratagene), 0´5 mmol/l dNTPs, one unit RNAse inhibitor, 5 units Stratascripte RT, 120 ng random hexamers (Gibco BRL, Carlsbad, CA, USA) in a 20-ml volume, incubated at 258C for 5 min followed by 428C for 50 min followed by 958C for 5 min (Table II) . Specific RT primers can also be used instead of random primers, although we noted no difference in sensitivity when using TAL-B-R (data not shown).
Real-time PCR reactions (Applied Biosystems) using 5 ml of the completed RT reaction were performed as directed by the manufacturer except that reaction volumes were decreased from 50 ml to 20 ml so as to use less reagents. PCR primers E2APBX-F1 and E2APBX-R were added at 100 ng each, whereas the E2APBX-D Taqmane probe was just 10 ng (again this used less of the expensive probe).
Reactions were then subjected to 5 min at 508C, 10 min at 958C, followed by 45 cycles of 958C for 15 s and 608C for 30 s. Data was collected and analysed with Applied Biosystem's sequence detection software (Version 1´7). Sample preparation. Whole cell RNA was extracted from several cell lines obtained from ATCC (Manassas, VA, USA) or Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ, Braunschweig, Germany) (Table III) . Kasumi-1 was kindly provided by Dr Nanao Kamada (Research Institute of Nuclear Medicine and Biology, Hiroshima, Japan) and used with permission. The RCH±ACV cell line was kindly provided by Dr Mignon Loh (Department of Paediatrics, University of California San Francisco, CA, USA). Colon RNA obtained from Stratagene served as a negative control in all experiments as well as background RNA in which the E2A±PBX1 runoff transcripts could be concealed to mimic the real life situation.
b2-Microglobulin (b2MG) mRNA expression was used to normalize results, and permitted RNA quantification and efficiency of the RT reaction to be determined. Primers for b2MG PCR were as previously described (Pallisgaard et al, 1999) . After the RT reaction, 2 ml of the cDNA cocktail were added to a separate real-time PCR assay for b2MG expression. Briefly, the assay contained 10 ml of Taqman Universal Master Mix (Applied Biosystems), 60 ng of the forward and reverse primers and 6 ng of a TET-labelled TaqMane Probe. Known amounts of RNA (colon RNA used as a negative control) generated the standard Ct values for that amount of RNA. These sample b2MG Ct values were then divided by the average colon Ct values generating a factor to correct for variations in the amounts of sample RNA. ). Mean Ct values are indicated by bar with standard errors (boxes) and deviations (whiskers). The likelihood ratio test was unable to demonstrate any difference between any of the individual experiments. Although 500 ag of the runoff transcript could be detected with the assay, its reliability was inconsistent and this standard point has been excluded from the standard curve. The resolution of the assay is 5 fg of transcript in a background of 500 ng of RNA. 
RESULTS
Standard curves were prepared such that each standard point was replicated at the RT step four times. ). There was little or no difference between standard curves prepared for different experiments (likelihood ratio test, x 2 0´31, d.f. 2, P 0´86). Figure 1 shows the data from five separate standard curve experiments combined. Resolution of the real-time RT-PCR assay permitted 5 fg of E2A±PBX1 fusion gene runoff transcript to be consistently detected. Attempts to detect attogramme (ag) amounts of the runoff transcript were unsuccessful although, occasionally, 500 ag of the fusion gene could be detected. The use of a nested PCR primer design would probably permit those levels to be routinely reached. However, such methods are increasingly susceptible to cross contamination and should, if possible, be avoided. Resolution demonstrated by the present method was sufficient to assay for transcript expression levels in several cell lines, and is probably sufficient for measuring minimal residual disease in patients whose leukaemic cells bear this translocation.
Minor variances in the RNA amounts assayed, owing either to measurement (by spectrophotometer) or pipette error, were accounted for by normalization against the b2MG gene. Known amounts of colon RNA were assayed in each experiment and consistently yielded the same Ct values (16´94^SE 0´07, SD 0´32). b2MG Ct values for samples were divided by that figure, thus providing a correction factor to apply against the sample RNA amounts (data not shown). These corrections were relatively minor in every case.
Cell lines 697 and RCH±ACV, both of which bear cytogenetically detectable t(1;19), had considerable E2A± PBX1 expression levels, with hundreds of transcripts per cell (Fig 2) . These calculations are based on the assumption that an average growing cell has 4 pg of whole cell RNA. For reasons that are unclear, RCH±ACV had a threefold higher level of fusion gene transcripts than 697 (t-test, P , 10
26
). In addition, RCH±ACV had considerable variation in E2A±PBX1 expression levels, particularly between different RNA extractions. For this reason, this cell line was assayed numerous times (n 40) to attempt to characterize the level of variation, the cause of which remained elusive. Several other cytogenetically negative cell lines were also assayed for the presence of E2A±PBX1 transcripts. Only one, the CEM line, demonstrated some expression. The CEM cell line yielded barely detectable amounts of the fusion gene, at expression levels of less than one copy per cell. It is likely this expression level is the result of a mixed population of cells in the cell culture, with only a small fraction of the cells bearing the fusion gene, or that in this cell line the fusion gene message is relatively short lived compared with the other cell lines. Colon RNA, which was routinely assayed as a negative control, never demonstrated any expression of the fusion gene, nor did the HL-60, K-562, REH, or Kasumi-1 cell lines.
DISCUSSION
The E2A±PBX1 assay described here (protocol provided in Table II) is relatively simple to undertake and is exceedingly reliable and reproducible. With the increased detection resolution provided by this single round realtime PCR design, the method described here should be useful for the detection of minimal residual disease. We also plan to use it for the detection of E2A±PBX1 fusion gene transcripts generated in vitro after cell culture and chemical exposure and for determining the background frequency of t(1;19), if any, in normal human populations.
